Malaria Symptoms:
• Fever: One of the most typical signs of malaria is a high fever, which is frequently ac-
companied by chills and perspiration.
• Headache: Malaria frequently causes severe headaches, which are experienced by
many patients.
• Fatigue: Extreme weariness and weakness brought on by malaria might make it chal-
lenging to carry out regular tasks.
• Muscle and joint pain: Malaria can result in significant muscle and joint pain.
• Nausea and vomiting: Malaria can result in nausea and vomiting, which can cause
dehydration and further difficulties.
• Diarrhoea: Diarrhoea might worsen dehydration in some malaria patients and occur in
some cases.
• Anaemia: Anaemia, which can result from malaria, can induce weakness, exhaustion,
and breathlessness.
• Jaundice: In severe instances of malaria, the parasite can damage the liver, resulting in
a yellowing of the skin and eyes known as jaundice.
• Seizures: Malaria can, in rare instances, lead to seizures, particularly in young children.
Malaria pf/pv antigen:
• The Plasmodium parasite is what causes malaria, a parasitic illness. Plasmodium falci-
parum (Pf) and Plasmodium vivax (Pv) are two of the many Plasmodium species that
may cause malaria.
• The antigens produced by the Pf and Pv parasites, respectively, are referred to as Pf/Pv
antigen. These antigens are used in diagnostic testing to find out whether a patient's
blood contains parasites.
• The rapid diagnostic test (RDT), a straightforward and reasonably priced test that may
be carried out in a clinic or hospital environment, is one typical diagnostic test that em-
ploys Pf/Pv antigen. The RDT can produce findings in as little as 15-20 minutes and
can identify the presence of Pf/Pv antigen in a patient's blood.
• Pf/Pv antigen detection is crucial for malaria diagnosis and selecting the best course of
therapy. Additionally, it is used to determine malaria hotspots and assess the success
of malaria control initiatives.
More details and Accuracy:
• One of the most frequently used RDTs for the diagnosis of malaria is the Pf/Pv antigen
detection RDT.
• In this test, nitrocellulose membranes coated with monoclonal antibodies that are spe-
cific to Pf and Pv antigens are used in a lateral flow format. The test finds Pf or Pv anti-
gens, which signify an ongoing infection, in a patient's blood.
• In general, laboratory-based procedures like microscopy or PCR are thought to be
more accurate than rapid diagnostic tests (RDTs) that identify Pf/Pv antigen.
• RDTs are still frequently utilised, nevertheless, since they are easy to use, affordable,
and rapid to produce findings, which makes them valuable in situations where access
to lab facilities is constrained.
• Depending on the brand and the particular test utilised, the sensitivity and specificity of
Pf/Pv antigen RDTs might differ significantly. Sensitivity is the percentage of infected
people that test positive, whereas specificity is the percentage of healthy people who
test negative.
• The World Health Organisation (WHO) estimates that Pf/Pv antigen RDTs have a sensi-
tivity range of 85-95% and a specificity range of 90-99%. However, these numbers
might change based on the specific test utilised, the test's level of quality, and other
variables.
• Pf/Pv antigen assays are a useful tool for detecting malaria in resource-constrained ar-
eas where more precise laboratory-based tests may not be accessible, despite their
overall limitations.
Treatment and Vaccines for Malaria:
• Chloroquine: Chloroquine is an old and affordable antimalarial drug that works well
against a variety of Plasmodium species. However, chloroquine is no longer advised as
a first-line therapy in many places since some parasite strains have evolved resistance
to it.
• Artemisinin-based combination therapy (ACT): Current first-line therapy for Plas-
modium falciparum-caused uncomplicated malaria is artemisinin-based combination
therapy (ACT), which combines artemisinin derivatives and additional antimalarial med-
ications.
• Quinine: Quinine is an antimalarial drug that has been around for a while and is still
used in some circumstances, such the treatment of severe malaria.
• Atovaquone-proguanil: This combination drug, which is effective against a number of
Plasmodium species, is frequently used for the prevention and treatment of malaria in
travellers.
A crucial component of controlling malaria is prevention, in addition to antimalarial drugs
and vaccinations. Among the most crucial preventative steps are:
• Use of bed nets treated with insecticide: The danger of mosquito bites and the
spread of malaria can be decreased by sleeping under a bed net treated with insecti-
cide.
• Use of insect repellent: Covering exposed skin with insect repellent can help ward off
mosquito bites.
• Indoor residual spraying: Spraying pesticide on walls and other interior surfaces to kill
mosquitoes that come into touch with it is known as indoor residual spraying.
• Chemoprophylaxis: This prevents malaria infection by using antimalarial drugs before,
during, and after travel to a region where the disease is prevalent.
Treatment and Vaccines for Malaria in Uganda:
• Antimalarial drugs like artemisinin-based combination therapy (ACT), which is the ad-
vised first-line treatment for uncomplicated malaria caused by Plasmodium falciparum,
are often used in Uganda to treat the disease.
• Quinine, atovaquone-proguanil, and mefloquine are a few more antimalarial drugs that
might be employed.
• Before beginning treatment, the Ugandan Ministry of Health advises that all suspected
cases of malaria be verified with diagnostic testing. By doing so, the danger of the
emergence of drug resistance is decreased and the proper treatment is administered.
• The Ugandan Ministry of Health advises the use of indoor residual spraying, insecti-
cide-treated bed nets, and other mosquito control techniques as preventative mea-
sures.
• Additionally, chemoprophylaxis could be advised for tourists visiting high-risk regions.
Steps to avoid Malarial symptoms from beginning to severe with regards to cerebral
system:
• Preventing mosquito bites: is the best method to protect yourself against malaria. This
can be accomplished by donning long sleeves, using insect repellents, and sleeping
with a mosquito net.
• Take anti-malaria medicine: It's crucial to take anti-malaria medication if you're going
somewhere where the danger of malaria is high. Your doctor can help you decide which
medicine is best for you out of the many various varieties that are available.
• Seek fast medical attention: It's critical to visit a doctor right away if you develop any
malaria symptoms, including fever, chills, headaches, or muscular pains. A more ad-
vanced stage of the disease can be avoided with early detection and treatment.
• Keep yourself hydrated: since dehydration from malaria can intensify already-existing
symptoms. To keep hydrated, be sure to consume lots of liquids, particularly water.
• Rest: Reducing the intensity of your symptoms and assisting your body in battling the
illness are two benefits of rest.
Evidence based articles and links:
• “The World Health Organization (WHO) has published numerous guidelines and reports
on the diagnosis, treatment, and prevention of malaria, based on the latest scientific
evidence”. These can be accessed through the WHO website: https://www.who.int/
malaria/en/
• “Adding rapid diagnostic tests to community-based programmes for treating malaria
(Review)”. There are numerous articles on malaria treatment and prevention available in
the Cochrane Library: https://www.cochranelibrary.com/cdsr/doi/
10.1002/14651858.CD009527.pub3/pdf/full
• “The US Centers for Disease Control and Prevention (CDC) provides information on
malaria treatment and prevention for travelers, as well as information on the latest re-
search and clinical trials related to malaria”: https://www.cdc.gov/malaria/index.html
• “The Malaria Journal is an open-access journal that publishes articles on all aspects of
malaria, including treatment and prevention”. Many articles in this journal are based on
original research and clinical trials: https://malariajournal.biomedcentral.com/
• “Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic
test in the context of the presence of non-malaria fevers, prior anti-malarial use and
seasonal malaria transmission”: https://malariajournal.biomedcentral.com/articles/
10.1186/s12936-017-1941-6
• “A comparative laboratory diagnosis of malaria: microscopy versus rapid diagnostic
test kits”: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609291/
• “Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longi-
tudinal follow-up in Kampala, Uganda”: https://pubmed.ncbi.nlm.nih.gov/17556616/
• “Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction
for the Detection of Plasmodium falciparum Malaria in a Low-Transmission Area, Jazan
Region, Southwestern Saudi Arabia”: https://www.ncbi.nlm.nih.gov/pmc/articles/PM-
C9222139/
• “Preventing malaria in travellers”: https://www.ncbi.nlm.nih.gov/pmc/articles/PM-
C2427103/
• “Malaria Treatment (United States)”: https://www.cdc.gov/malaria/diagnosis_treatment/
treatment.html
• “Efficacy and safety of artemisinin-based combination therapies for the treatment of
uncomplicated malaria in pediatrics: a systematic review and meta-analysis”: https://
pubmed.ncbi.nlm.nih.gov/33827422/
• “Drug resistant parasites and fungi from a one-health perspective: A global concern
that needs transdisciplinary stewardship programs”: https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC8692089/